Ginkgo Bioworks Holdings Inc vs Grab Holdings Ltd. — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.58 (market cap $505.73M), while Grab Holdings Ltd. trades at $3.73 (market cap $15.26B). The key difference: Grab Holdings Ltd. is far larger — about 30.2× Ginkgo Bioworks Holdings Inc's market cap. Which is the better fit depends on your goals.
| DNA | GRAB | |
|---|---|---|
Market Cap | $505.73M | $15.26B |
Sector | Health | Technology |
52-Week High | $16.14 | $6.45 |
52-Week Low | $5.48 | $3.27 |
Enterprise Value | $607.68M | $10.99B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GRAB trades at $3.67, up 0.27% today, with a bullish technical signal from moving averages and strong earnings beats in recent quarters. Revenue grew to $3.37B in 2025, with net income turning positive at $268M, reflecting improved profitability. The company raised its 2026 guidance after Q2 results, driven by on-demand and financial services growth. Analyst consensus is strongly bullish with an average price target of $5.86, implying 58% upside.
The outlook is positive given consistent earnings outperformance and raised guidance, but risks include high valuation (P/E 34), insider selling, and projected negative cash flow in 2026. Investors should weigh growth momentum against execution challenges in competitive Southeast Asian markets.
Trailing returns across standard periods
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →